Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98

Podobné jednotky

• Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
  Autor: Koeberle, Dieter, a další
  Vydáno: (2007)
• Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
  Autor: Phillips, Kelly Anne, a další
  Vydáno: (2010)
• Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
  Autor: Regan, Meredith M, a další
  Vydáno: (2011)
• Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
  Autor: Ruhstaller, Thomas, a další
  Vydáno: (2019)
• Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
  Autor: Phillips, Kelly-Anne, a další
  Vydáno: (2010)